GPRC5D Bispecific antibody talquetamab-induced dizziness-ataxia syndrome, clinical presentation and management- a case series

類似資料

• Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma
  著者:: Verkleij, Christie P. M., 等
  出版事項: (2021)
• Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study
  著者:: Gang An, 等
  出版事項: (2025-10-01)
• A Rare Cause of Dizziness and Gait Ataxia: CLIPPERS Syndrome
  著者:: Maenhoudt, Wim, 等
  出版事項: (2016)
• Toxicities Associated with Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma
  著者:: Nathwani, Nitya, 等
  出版事項: (2020)
• Metronidazole, an Uncommon Cause of Dizziness and Ataxia in the Emergency Department: A Case Report
  著者:: Starrs, Mary E., 等
  出版事項: (2021)